Background: EUROCARE, a European population-based cancer project, has shown geographical survival disparities for myeloid neoplasms (MN) suggesting healthcare inequalities. Total National Health Expenditure (TNHE) might influence population-based MN survival. We studied the long-term survival of 15 MN and the TNHE impact on prognosis between European countries.
Methods: In this observational, retrospective, population-based study, we analysed the EUROCARE-6 dataset (comprising data from 27 European countries) of patients aged 15 or older diagnosed with a MN between 2001 and 2013, and followed up to December 31, 2014. Countries were classified according to their mean TNHE quartile in 2001-13. For each MN, 5-year and 10-year age-standardised relative survival (ASRS) was calculated using the period approach. Generalised linear models indicated the effects of age at diagnosis, sex, and TNHE on the relative excess risk of death (RER).
Findings: We identified 267 968 MN cases [median follow-up time: 13 years (IQR 13-14)]. The 10-year ASRS was highest for myeloproliferative neoplasms (MPN) (61.2 % [95 % CI 60.3-62.0 %]), in particular chronic myeloid leukaemia (52.5 % [95 % CI 51.1-53.9 %]), polycythemia vera (70.9 % [95 % CI 69.0-72.8 %]), essential thrombocythemia (75.2 % [95 % CI 73.3-77.1 %]), and lowest for acute myeloid leukaemia (AML) (15.6 % [95 % CI 15.2-16.1 %]), except for acute promyelocytic leukaemia (52.2 % [95 % CI 46.3-58.7 %]). For AML, MPN, myelodysplastic syndrome, 5-year and 10-year ASRS was higher in countries in the highest TNHE quartile (high expenditure) than countries in the lowest quartile (low expenditure). Ten-year RERs for almost all MN increased with decreasing health expenditure, albeit not uniformly.
Interpretation: TNHE is associated with geographical inequalities in MN prognosis. Policy decisions on allocating economic resources are needed to reduce these differences.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejca.2025.115231 | DOI Listing |
Am J Physiol Endocrinol Metab
March 2025
MaineHeath Institute for Research, Center for Molecular Medicine, Scarborough, Maine, United States.
Obesity is a global health challenge associated with significant metabolic and cardiovascular risks. Bariatric surgery and GLP-1 receptor agonists (GLP-1RAs) are effective interventions for weight loss and metabolic improvement, yet their comparative effects on systemic metabolism-particularly energy metabolism, bone health, and heart function-remain unclear. In this study, obese male mice underwent vertical sleeve gastrectomy (VSG), 6 weeks of GLP-1RA (semaglutide) treatment, or sham procedure with saline injection as controls.
View Article and Find Full Text PDFAm J Prev Med
January 2025
State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China; Key Laboratory of Health Technology Assessment of Fujian Province, School of Public Health, Xiamen University, Xiamen, China. Electronic address:
Introduction: The purpose of this article is to describe the global burden and temporal trends of Alzheimer's disease and other dementias from 1990 to 2021 and explore cross-country inequality associated with sociodemographic development-related factors.
Methods: The disability-adjusted life years of Alzheimer's disease and other dementias and sociodemographic index were extracted from the Global Burden of Disease 2021 study, and other sociodemographic development-related factors, including government expenditure on education (% of GDP), net national income per capita, health expenditure per capita, and fertility rate, were sourced from World Bank Data. Disability-adjusted life years of Alzheimer's disease and other dementias across 204 countries/territories and global age-sex distribution in 2021 were illustrated.
J Opioid Manag
March 2025
SA Pharmacy, Government of South Australia, Adelaide, Australia. ORCID: https://orcid.org/0000-0003-4786-022X.
Introduction: Chronic pain is a leading cause of chronic disease in Australia, with a 2020 report indicating that one in five Australians aged over 45 experience chronic pain. The high prevalence of chronic pain accounts for significant healthcare utilization and associated costs, with the economic impact of chronic pain estimated to be AUD$139 billion in 2018.
Case Presentations: This paper uses two exemplar cases to demonstrate inadequacies within the current systems supporting those with chronic pain and the associated impacts these inadequacies have on patient outcomes and healthcare costs.
Acta Physiol (Oxf)
April 2025
Department of Nutrition, University of Massachusetts, Amherst, Massachusetts, USA.
Aim: Aging decreases the metabolic rate and increases the risk of metabolic diseases, highlighting the need for alternative strategies to improve metabolic health. Heat treatment (HT) has shown various metabolic benefits, but its ability to counteract aging-associated metabolic slowdown remains unclear. This study aimed to investigate the impact of whole-body HT on energy metabolism, explore the potential mechanism involving the heat sensor TRPV1, and examine the modulation of gut microbiota.
View Article and Find Full Text PDFPrior studies of the role of state spending on home and community-based services (HCBS) in nursing home use focused on adults over the age of 65. However, medically complex children and adults under 50 years old represent a small (about 5%) but highly vulnerable subset of nursing home patients. We measured the impact of HCBS spending on short-term and long-term nursing home stays by children and adults under 44 years old and compared the impact between Non-Hispanic White (NHW) individuals and Black, Indigenous, and People of Color (BIPOC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!